ME
Insider selling
Mark Elliott Boulding sold $12K of Ptc Therapeutics, Inc. (PTCT) stock
Mark Elliott Boulding, Exec. VP And Clo of Ptc Therapeutics, Inc. (PTCT), sold 192 shares of PTCT stock worth $12K, per an SEC Form 4 filed Oct 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 9, 2026, 4 days before it was made public.
PTCT has moved +0.0% since the trade date, from $64.70 to $64.70 (Oct 9, 2026 close).
- Traded
- Oct 9, 2026
- Disclosed
- Oct 13, 2026
- Filing delay
- 4 days
- Price since
- +0.0%
- Role
- Exec. VP And Clo
- Source
- SEC Form 4
More PTCT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.